Wednesday Nov 27, 2024
Wednesday Nov 27, 2024
Friday, 19 April 2024 00:22 - - {{hitsCtrl.values.hits}}
The Transparency International Sri Lanka (TISL) on Tuesday filed a Fundamental Rights Application (SCFR/ 99/2024) at the Supreme Court highlighting the serious ramifications on the health sector and the general public from the recent controversial procurement of medical supplies including human immunoglobulin (Human-IG).
The Cabinet of Ministers, the incumbent and former higher officials in the health sector, former Health Minister Keheliya Rambukwella, the companies involved in the controversial supplies of Human-IG, Treasury Secretary, Auditor General, Director General of Customs, Inspector General of Police, Members and Director General of CIABOC and the Attorney General are among the 66 Respondents named in the Petition.
The FR application has been filed in the public interest, with the aim of seeking accountability for the misuse of public resources and the violation of fundamental rights of citizens.
The petition requests the Court to declare that the purported decision of the Cabinet of Ministers and the health authorities to procure medical supplies from Isolez Biotech Pharma AG Ltd., Livealth BioPharma Ltd., Yaden International Ltd., Nandani Medical Laboratories Ltd., Divine Laboratories Ltd., Gulfic Biosciences Ltd., Novachem Lanka Ltd., and Slim Pharmaceuticals Ltd., is wrongful, illegal, unlawful, null and void, and of no force or avail in law.
Arguing that the actions or inactions of the Respondents amount to an infringement of the fundamental rights guaranteed under the Constitution, the Petitioners seek the intervention of the Court to review the issuance of Waivers of Registration in procuring medical supplies and direct the Respondents to comply with the procedural safeguards imposed by law, regulations and rules to ensure transparency in procurement.
“It is evident that the alleged ‘emergency’ which prevailed in the healthcare sector was largely owing to mismanagement, giving rise to concerns as to whether such gross mismanagement is indicative of the machinations of individuals holding office in inter alia the Ministry of Health, who orchestrated the said emergency for ulterior motives,” the Petition states.
The latest action is in addition to TISL’s ongoing Petition (SCFR/65/2023), which was filed in February 2023, in view of the glaring malpractices and disregard for compliance with law when importing pharmaceuticals under the Indian Credit Line.
TISL, in its latest FR application, requests the Court to direct the Auditor General to conduct a special inquiry into the decision to procure medical supplies from medical suppliers to whom Waivers of Registration had been issued, and compute the cost incurred by procuring medical supplies through them.
In addition, it requests the Court to direct the Attorney General (AG) to commence prosecution of persons identified to have obtained financial or other benefits through the procurement of medical supplies through the use of Waivers of Registration. It further requests the Court to direct the AG to recover the costs incurred to the State or the public and seek compensation from the relevant parties mentioned in the Petition.
